A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
PHASE2
The purpose of this study is to determine whether ramucirumab when used in ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
PHASE2
This research study is being down to find what, effects, good and/or bad, a...
Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma
PHASE1
This is an open-label, dose-escalation and dose-expansion phase Ib/IIa clin...